CORRECTING and REPLACING Elizabeth Arden, Inc. Announces Second Quarter Fiscal 2013 Results

  CORRECTING and REPLACING Elizabeth Arden, Inc. Announces Second Quarter
  Fiscal 2013 Results

                ~ Net Sales of $468 Million; Increase of 9% ~

                  ~ Adjusted EPS of $1.58; Increase of 11% ~

~ Fiscal Year-to-Date Net Sales Increase of 11%; Adjusted EPS Increase of 17%
                                      ~

CORRECTION...by Elizabeth Arden, Inc.

Business Wire

NEW YORK -- February 4, 2013

A correction was made to the "Segment Net Sales" table in the release dated
January 31, 2012. In the "Three Months Ended" section, the "%
Increase/(Decrease)" figures were corrected.

The corrected release reads:

      ELIZABETH ARDEN, INC. ANNOUNCES SECOND QUARTER FISCAL 2013 RESULTS

                ~ Net Sales of $468 Million; Increase of 9% ~

                  ~ Adjusted EPS of $1.58; Increase of 11% ~

~ Fiscal Year-to-Date Net Sales Increase of 11%; Adjusted EPS Increase of 17%
                                      ~

Elizabeth Arden, Inc. (NASDAQ: RDEN), a global prestige beauty products
company, today announced financial results for its second fiscal quarter ended
December 31, 2012.

SECOND QUARTER RESULTS

For the quarter ended December 31, 2012, the Company reported net sales of
$467.9 million, an increase of 8.8% as compared to the second quarter of the
prior fiscal year. Excluding the unfavorable impact of foreign currency
translation, net sales increased by 9.1%.

On a reported basis, net income per diluted share for the current year period
was $1.47. On an adjusted basis, net income per diluted share for the quarter
ended December 31, 2012 was $1.58, as compared to net income per diluted share
of $1.42 for the prior year period. Adjusted net income per diluted share
excludes acquisition-related expenses and non-recurring charges associated
with the Elizabeth Arden brand repositioning. A reconciliation between GAAP
and adjusted results can be found in the tables and footnotes at the end of
this press release.

In North America, net sales increased 8.4% for the quarter and 13% fiscal
year-to-date. The Company's fragrance portfolio continued to add market share,
with both prestige and mass retailers gaining 2.15% and 2.1%, respectively.
Sales growth was driven by the recently acquired brands, new launches,
including Justin Bieber's Girlfriend, Pink Friday Nicki Minaj and Taylor Swift
Wonderstruck Enchanted, which all ranked among the top fragrance launches in
U.S. prestige department stores for the holiday season, and growth in existing
pillar fragrance brands. Performance at prestige retailers was strong with a
number of the Company's key existing brands as well, with the largest retail
sales increases posted by the Juicy Couture, John Varvatos and Curve
fragrances. Net sales of Elizabeth Arden branded products decreased 6% for the
quarter and 6.5% fiscal year-to-date in North America. In terms of retail
sales, overall retail sales at Elizabeth Arden counters in North America were
flat, with the Company's recently converted Elizabeth Arden flagship counters
increasing 24% year over year since conversion through the end of December.

Internationally, net sales grew 11% (constant rates) for the second fiscal
quarter and 10% (constant rates) fiscal year-to-date. Net sales of fragrances
increased 14% (constant rates) for the first six months, behind the Company's
Western European fragrance initiative. As a result, fragrance sales in Europe
grew 18% (constant rates) during the same period. Net sales of Elizabeth Arden
branded products grew 10% (constant rates) for the second quarter and 7%
(constant rates) for the first half of the fiscal year. As for retail sales
performance, retail sales of Elizabeth Arden products at international
flagship doors increased by 9% since conversion, reflecting later conversion
dates as compared to the flagship doors in North America.

E. Scott Beattie, Chairman, President and Chief Executive Officer of Elizabeth
Arden, Inc., commented, "Second quarter sales and earnings were up solidly
from the prior year, with strong retail sales performance within our North
America and International businesses. Nonetheless, our net sales results were
below original guidance due to lower than forecasted sales in department
stores as well as softer than anticipated holiday sales at one of our major
mass retail accounts. Despite strong sales growth among many of our global
affiliates, international net sales were impacted by lower than expected
inventory replenishment in our travel retail business and weakness in Greater
China."

Mr. Beattie continued, "Over the course of the past few months, we
successfully completed the conversion of our Elizabeth Arden flagship doors
and are very excited with the momentum of sales increases. The flagship model
was established as a way for us to test, learn, and gather feedback on the
repositioning of the Elizabeth Arden brand as well as build confidence in the
growth potential of the brand with our key retail partners. Flagship counters
in the North American markets were converted earlier this fall, with all door
conversions complete by the end of October. U.S. flagship doors delivered 24%
year-over-year retail sales growth from conversion through the end of
December, well in excess of the U.S. prestige category which grew 5% for the
second quarter.

"The timing of the conversion of international flagship doors was staggered
across the quarter due to retailer constraints. International flagship doors
delivered 9% retails sales growth from conversion, reflecting later conversion
dates as compared to the flagship doors in North America, and are gaining
momentum by the week. The most recent weeks have achieved retail sales growth
of 23%. Given our early success, we plan to extend key elements of the
flagship model to the next tier of approximately 200 doors globally during the
remainder of fiscal 2013 and drive sales growth behind the roll out of new
products for our international markets during the second half of the fiscal
year."

SIX MONTH RESULTS

For the six months ended December 31, 2012, the Company reported net sales of
$812.5 million, an increase of 10.8%, as compared to the prior year period.
Excluding the unfavorable impact of foreign currency translation, net sales
increased by 12%. On a reported basis, net income per diluted share for the
six months ended December 31, 2012 was $1.54. On an adjusted basis, net income
per diluted share was $2.02, as compared to net income per diluted share of
$1.73 for the prior year period. Adjusted net income per diluted share
excludes acquisition-related expenses and non-recurring charges associated
with the Elizabeth Arden brand repositioning. A reconciliation between GAAP
and adjusted results can be found in the tables and footnotes at the end of
this press release.

OUTLOOK

Based on the retail trends year-to-date and the seasonally slower fragrance
market in the second fiscal half, the Company is reducing its second half
revenue and earnings guidance. For the full fiscal year ending June 30, 2013,
the Company currently expects net sales to increase by 9% to 11%, assuming an
expected unfavorable impact from foreign currency of approximately 0.5%, as
compared to the prior year period, and for earnings per diluted share
(adjusted) to be in the range of $2.30 to $2.50. The Company currently expects
gross margin (adjusted) for fiscal 2013 to increase by 75 to 100 basis points
as compared to gross margin (adjusted) for fiscal 2012.

For the third quarter of fiscal 2013, the Company is introducing guidance for
net sales of $255 million to $270 million, and for net income per diluted
share of $0.00 to $0.04. The net sales guidance for the third quarter of
fiscal 2013 assumes an unfavorable impact from foreign currency rates of
approximately 0.2%, as compared to rates in effect for the prior year period.

The earnings guidance excludes non-recurring charges related to the Elizabeth
Arden brand repositioning and expenses related to the acquisitions completed
in the fourth quarter of fiscal 2012. The Company expects to incur the
remainder of these charges, currently estimated at $4.3 million (pre-tax),
primarily in the third quarter of fiscal 2013.

The guidance is based on current foreign currency rates. The Company also
notes that continued global economic uncertainty may have a negative effect on
retailer and consumer confidence and demand, and, along with the foreign
currency volatility, makes forecasting difficult.

CONFERENCE CALL INFORMATION

The Company will host a conference call today at 9:30 a.m. Eastern Time. All
interested parties can listen to a live web cast of the Company's conference
call by visiting the Investor Relations section of the Corporate tab on the
Company's web site at http://ir.elizabetharden.com. An online archive of the
broadcast will be available within one hour of the completion of the call and
will be accessible on the Company's web site until March 1, 2013.

Elizabeth Arden is a global prestige beauty products company with an extensive
portfolio of prestige beauty brands sold in over 120 countries. The company's
brand portfolio includes Elizabeth Arden skincare, color and fragrance
products, the celebrity fragrance brands of Britney Spears, Elizabeth Taylor,
Justin Bieber, Mariah Carey, Nicki Minaj, Taylor Swift, and Usher; the
designer fragrance brands of Juicy Couture, Alfred Sung, BCBGMAXAZRIA,
Geoffrey Beene, Halston, Ed Hardy, John Varvatos, Kate Spade, Lucky Brand,
True Religion and Rocawear; and the lifestyle fragrance brands Curve, Giorgio
Beverly Hills, and PS Fine Cologne.

                                                                                  
                                                                                  
ELIZABETH ARDEN, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENT OF INCOME DATA

(Unaudited)

(In thousands, except percentages and per share data)
                                                  
                          Three Months Ended            Six Months Ended
                          December     December        December     December
                          31,           31,             31,           31,
                          2012          2011           2012          2011
Net Sales                 $ 467,919     $ 429,926       $ 812,460     $ 733,460
                                                                                  
Cost of Goods Sold:
Cost of Sales               229,966       211,012         425,577       370,767
Depreciation
Related to Cost of         1,487       1,601         3,018       2,944   
Goods Sold
Total Cost of Goods         231,453       212,613         428,595       373,711
Sold
                                                                                  
Gross Profit                236,466       217,313         383,865       359,749
Gross Profit                50.5    %     50.5    %       47.2    %     49.0    %
Percentage
                                                                                  
Selling, General
and Administrative          163,253       148,451         292,660       266,898
Expenses
Depreciation and           9,372       7,070         18,501      13,788  
Amortization
Total Operating             172,625       155,521         311,161       280,686
Expenses
                                                                                  
Interest Expense,           6,424         5,786           12,622        11,048
Net
                                                                                  
Income Before               57,417        56,006          60,082        68,015
Income Taxes
Provision for              12,608      13,635        13,089      16,412  
Income Taxes
Net Income                $ 44,809     $ 42,371       $ 46,993     $ 51,603  
                                                                                  
As reported:
                                                                                  
Net Income Per            $ 1.51        $ 1.46          $ 1.59        $ 1.78
Basic Share
Net Income Per            $ 1.47        $ 1.42          $ 1.54        $ 1.73
Diluted Share
                                                                                  
Basic Shares                29,680        28,980          29,617        28,925
Diluted Shares              30,492        29,917          30,498        29,913
                                                                                  
EBITDA (a)                $ 74,700      $ 70,463        $ 94,223      $ 95,795
EBITDA margin (a)           16.0    %     16.4    %       11.6    %     13.1    %
                                                                                  
Adjusted to exclude
acquisition-related
and

Elizabeth Arden
repositioning
costs, net of

taxes (b)(c):
                          
Gross Profit              $ 241,898     $ 217,313       $ 404,017     $ 359,749
Gross Profit                51.7    %     50.5    %       49.7    %     49.0    %
Percentage
                                                                                  
Net Income                $ 48,057      $ 42,371        $ 61,498      $ 51,603
                                                                                  
Net Income Per            $ 1.62        $ 1.46          $ 2.08        $ 1.78
Basic Share
Net Income Per            $ 1.58        $ 1.42          $ 2.02        $ 1.73
Diluted Share
                                                                                  
EBITDA (a)                $ 80,514      $ 70,463        $ 115,101     $ 95,795
EBITDA margin (a)           17.2    %     16.4    %       14.2    %     13.1    %
                                                                                  

(a) EBITDA is defined as net income plus the provision for income taxes plus
interest expense, plus depreciation and amortization. EBITDA should not be
considered as an alternative to income from operations or net income (as
determined in accordance with generally accepted accounting principles (GAAP))
as a measure of our operating performance or to net cash provided by
operating, investing and financing activities (as determined in accordance
with GAAP) or as a measure of our ability to meet cash needs. We believe that
EBITDA is a measure commonly reported and widely used by investors and other
interested parties as a measure of a company's operating performance and debt
servicing ability because it assists in comparing performance on a consistent
basis without regard to capital structure, depreciation and amortization or
non-operating factors (such as historical cost). Accordingly, as a result of
our capital structure, we believe EBITDA is a relevant measure. This
information has been disclosed here to permit a more complete comparative
analysis of our operating performance relative to other companies and of our
debt servicing ability. EBITDA may not, however, be comparable in all
instances to other similar types of measures. We have also disclosed EBITDA as
adjusted without giving effect to acquisition-related and Elizabeth Arden
repositioning costs. This disclosure is being provided for comparability
purposes because we believe it is meaningful to our investors and other
interested parties to understand the EBITDA performance of the Company on a
consistent basis without regard to the effect of acquisition-related and
Elizabeth Arden repositioning costs.

The table below reconciles net income, as determined in accordance with GAAP,
to EBITDA and to EBITDA as adjusted: (For a reconciliation of net income to
EBITDA for prior periods, see the Company's filings with the Securities and
Exchange Commission which can be found on the Company's website at
www.elizabetharden.com.)

   (In thousands)         Three Months Ended    Six Months Ended
                                December   December     December    December
                                31,       31,          31,        31,
                                2012       2011         2012        2011
      Net income                $ 44,809   $ 42,371     $ 46,993    $ 51,603
      Plus:
      Provision for               12,608     13,635       13,089      16,412
      income taxes
      Interest expense,           6,424      5,786        12,622      11,048
      net
      Depreciation
      related to cost of          1,487      1,601        3,018       2,944
      goods sold
      Depreciation and           9,372     7,070       18,501     13,788
      amortization
      EBITDA                      74,700     70,463       94,223      95,795
      Acquisition-related
      and Elizabeth Arden        5,814     --          20,878     --
      repositioning
      costs (c)
      EBITDA as adjusted        $ 80,514   $ 70,463     $ 115,101   $ 95,795
                                                                             

The table below reconciles net cash flow (used in) provided by operating
activities, as determined in accordance with GAAP, to EBITDA:

                                      
      (Amounts in thousands)                   Six Months Ended
                                               December 31,   December 31,
                                               2012             2011
      Net cash (used in) provided by           $  (10,888 )     $  49,169
      operating activities
      Changes in assets and
      liabilities, net of                         92,306           35,998
      acquisitions
      Interest expense, net                       12,622           11,048
      Amortization of senior note
      offering and credit facility                (682    )        (621    )
      costs
      Provision for income taxes                  13,089           16,412
      Deferred income taxes                       (9,376  )        (13,711 )
      Amortization of share-based                (2,848  )       (2,500  )
      awards
      EBITDA                                   $  94,223       $  95,795  
                                                                             

(b) The table below reconciles the calculation of (i) net income and (ii) net
income per share on a basic and diluted basis from the amounts reported in
accordance with GAAP to such amounts before giving effect to
acquisition-related and Elizabeth Arden repositioning costs. This disclosure
is being provided for comparability purposes because we believe it is
meaningful to our investors and other interested parties to understand the
Company's operating performance on a consistent basis without regard to the
effect of acquisition-related and Elizabeth Arden repositioning costs. The
presentation in the table below of the non-GAAP information titled "Net income
as adjusted" and "Net income per basic and diluted share as adjusted" is not
meant to be considered in isolation or as a substitute for net income or net
income per basic and diluted share prepared in accordance with GAAP.

                                                 
(In thousands,
except per share           Three Months Ended          Six Months Ended
data)
                           December     December      December   December
                           31,           31,           31,         31,
                           2012          2011          2012        2011
                                                                             
Gross Profit:
Gross Profit as            $  236,466    $ 217,313     $ 383,865   $ 359,749
reported
Acquisition-related
and Elizabeth Arden          5,432       --           20,152     --
repositioning
costs (c)
Gross Profit as            $  241,898    $ 217,313     $ 404,017   $ 359,749
adjusted
                                                                             
Net Income Per Basic
Share:
Net income per basic       $  1.51       $ 1.46        $ 1.59      $ 1.78
share as reported
Acquisition-related
and Elizabeth Arden
repositioning                0.11        --           0.49       --
costs, net of tax
(c) (d)
Net income per basic       $  1.62       $ 1.46        $ 2.08      $ 1.78
as adjusted
                                                                             
Net Income Per
Diluted Share:
Net income per
diluted share as           $  1.47       $ 1.42        $ 1.54      $ 1.73
reported
Acquisition-related
and Elizabeth Arden
repositioning                0.11        --           0.48       --
costs, net of tax
(c) (d)
Net income per
diluted share as           $  1.58       $ 1.42        $ 2.02      $ 1.73
adjusted
                                                                             

(c) For the three months ended December 31, 2012, gross profit and net income
include $1.9 million (pre-tax) of inventory–related costs primarily for
inventory purchased by us from New Wave Fragrances LLC and Give Back Brands
LLC prior to the fragrance license acquisitions from those companies and $3.6
million (pre-tax) of costs related to the repositioning of the Elizabeth Arden
brand. In addition, net income includes $0.3 million (pre-tax) of expenses
related to the repositioning of the Elizabeth Arden brand that were recorded
in selling, general and administrative expenses. For the six months ended
December 31, 2012, gross profit and net income include $13.2 million (pre-tax)
of inventory–related costs ($6.4 million of which did not required the use of
cash in the current period) primarily for inventory purchased by us from New
Wave Fragrances LLC and Give Back Brands LLC prior to the fragrance license
acquisitions from those companies and $7.0 million (pre-tax) of costs related
to the repositioning of the Elizabeth Arden brand. In addition, net income
includes $0.3 million (pre-tax) in transition costs associated with the New
Wave Fragrances LLC and Give Back Brands LLC acquisitions and $0.4 million
(pre-tax) of expenses related to the repositioning of the Elizabeth Arden
brand that were recorded in selling, general and administrative expenses.

(d) Our effective tax rate on a reported basis, which is calculated as a
percentage of income before income taxes, was 22.0% and 21.8% for the three
and six months ended December 31, 2012, respectively. On a reported basis, for
the three and six months ended December 31, 2011, our effective tax rate was
24.3% and 24.1%, respectively. On an adjusted basis, for both the three and
six months ended December 31, 2012, our effective tax rate was 24.0%.


SEGMENT NET SALES

The table below is a comparative summary of our net sales by reportable
segment for the three and six months ended December 31, 2012 and 2011:

                                                                                  
(In               Three Months Ended        % Increase           Six Months Ended          % Increase
thousands)                                  (Decrease)                                     (Decrease)
                  December    December              Constant     December    December               Constant
                  31,        31,           GAAP   Rates        31,        31,           GAAP    Rates
                  2012        2011                  (e)          2012        2011                   (e)
Segment Net                                                                                    
Sales
North America     $ 311,077   $ 287,095     8.4 %   8.2   %      $ 542,634   $ 480,061     13.0 %   13.0  %
International      156,842   142,831     9.8 %  11.0  %       269,826   253,399     6.5  %  10.1  %
                                                                                                             
Total             $ 467,919   $ 429,926     8.8 %   9.2   %      $ 812,460   $ 733,460     10.8 %   12.0  %


PRODUCT CATEGORY NET SALES

The table below is a comparative summary of our net sales by product category
for the three and six months ended December 31, 2012 and 2011:

                                                                              
(In            Three Months Ended      % Increase          Six Months Ended        % Increase
thousands)                             (Decrease)                                  (Decrease)
               December    December             Constant   December    December              Constant
               31,        31,         GAAP    Rates      31,        31,         GAAP     Rates
               2012        2011                 (e)        2012        2011                  (e)
Product
Category                                                                                
Net Sales:
Elizabeth
Arden          $ 147,957   $ 143,568   3.1  %   3.8   %    $ 256,436   $ 257,866   (0.6 )%   1.7   %
Brand
Celebrity,
Lifestyle,
Designer      319,962   286,358   11.7 %  11.9  %     556,024   475,594   16.9 %   17.6  %
and
Other
Fragrances
Total          $ 467,919   $ 429,926   8.8  %   9.2   %    $ 812,460   $ 733,460   10.8 %    12.0  %
                                                                                                      

(e) Constant currency information compares results between periods assuming
exchange rates had remained constant period-over-period and excludes gains and
losses from foreign currency contracts in all periods. We calculate constant
currency information by translating current-period results using prior-year
GAAP foreign currency exchange rates. The gains and/or losses from foreign
currency contracts were not material for all periods presented.

                                                                             
                                                                             
ELIZABETH ARDEN, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEET DATA

(Unaudited)
                                                        
(In thousands)                 December 31,     June 30,        December 31,
                               2012             2012            2011
Cash                           $  46,003        $ 59,080        $   62,340
Accounts Receivable, Net          288,479         188,141           216,877
Inventories                       322,835         291,987           264,632
Property and Equipment,           91,769          89,438            78,981
Net
Exclusive Brand
Licenses, Trademarks and          305,598         314,502           224,028
Intangibles, Net
Goodwill                          21,054          21,054            21,054
Total Assets                      1,168,683       1,066,754         954,736
Short-Term Debt                   103,500         89,200            -
Current Liabilities               334,058         278,679           212,047
Long-Term Liabilities             295,686         306,348           267,406
Long-Term Debt                    250,000         250,000           250,000
Shareholders' Equity              538,939         481,727           475,283
Working Capital                   392,422         345,818           402,445

                                                                      
        SUPPLEMENTARY CASH FLOW INFORMATION

        (Unaudited)

        (In thousands)
                                   
                                         Six Months Ended
                                         December 31,    December 31,
                                         2012               2011
                                                                             
        Net cash (used in)
        provided by operating            $  (10,888 )       $  49,169
        activities
        Net cash used in                    (27,072 )          (52,990 )
        investing activities
        Net cash provided by                24,816             9,164
        financing activities
        Net (decrease)
        increase in cash and                (13,077 )          3,490
        cash equivalents
                                                                             

In connection with the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995, Elizabeth Arden, Inc. is hereby providing
cautionary statements identifying important factors that could cause our
actual results to differ materially from those projected in forward-looking
statements (as defined in such act). Any statements that are not historical
facts and that express, or involve discussions as to, expectations, beliefs,
plans, objectives, assumptions or future events or performance (often, but not
always, indicated through the use of words or phrases such as "will likely
result," "are expected to," "will continue," "is anticipated," "should,"
"estimated," "intends," "plans," "believes" and "projects") may be
forward-looking and may involve estimates and uncertainties which could cause
actual results to differ materially from those expressed in the
forward-looking statements. These statements include, but are not limited to,
our guidance and expectations regarding net sales, earnings, gross margins,
operating cash flow and returns on invested capital. In addition, any such
statements are qualified in their entirety by reference to, and are
accompanied by, the following key factors that have a direct bearing on our
results of operations:

    factors affecting our relationships with our customers or our customers'
    businesses, including the absence of contracts with customers, our
    customers' financial condition, and changes in the retail, fragrance and
*  cosmetic industries, such as the consolidation of retailers and the
    associated closing of retail doors as well as retailer inventory control
    practices, including, but not limited to, levels of inventory carried at
    point of sale and practices used to control inventory shrinkage;
    risks of international operations, including foreign currency
    fluctuations, hedging activities, economic and political consequences of
*   terrorist attacks, disruptions in travel, unfavorable changes in U.S. or
    international laws or regulations, diseases and pandemics, and political
    instability in certain regions of the world;
*   our reliance on license agreements with third parties for the rights to
    sell many of our prestige fragrance brands;
    our reliance on third-party manufacturers for substantially all of our
*   owned and licensed products and our absence of contracts with suppliers of
    distributed brands and components for manufacturing of owned and licensed
    brands;
    delays in shipments, inventory shortages and higher supply chain costs due
*   to the loss of or disruption in our distribution facilities or at key
    third party manufacturing or fulfillment facilities that manufacture or
    provide logistic services for our products;
    our ability to respond in a timely manner to changing consumer preferences
*   and purchasing patterns and other international and domestic conditions
    and events that impact retailer and/or consumer confidence and demand,
    such as domestic or global recessions or economic uncertainty;
*   our ability to protect our intellectual property rights;
*   the success, or changes in the timing or scope, of our new product
    launches, advertising and merchandising programs;
*   the quality, safety and efficacy of our products;
*   the impact of competitive products and pricing;
    our ability to (i) implement our growth strategy and acquire or license
    additional brands or secure additional distribution arrangements, (ii)
*   successfully and cost-effectively integrate acquired businesses or new
    brands, and (iii) finance our growth strategy and our working capital
    requirements;
    our level of indebtedness, our ability to realize sufficient cash flows
*   from operations to meet our debt service obligations and working capital
    requirements, and restrictive covenants in our revolving credit facility,
    term loan and the indenture for our 7 3/8% senior notes;
*   changes in product mix to less profitable products;
*   the retention and availability of key personnel;
    changes in the legal, regulatory and political environment that impact, or
    will impact, our business, including changes to customs or trade
*   regulations, laws or regulations relating to ingredients or other
    chemicals or raw materials contained in products or packaging, or
    accounting standards or critical accounting estimates;
*   the success of our global Elizabeth Arden brand repositioning efforts;
    the impact of tax audits, including the ultimate outcome of the pending
*   Internal Revenue Service examination of our U.S. federal tax returns for
    the fiscal years ended June 30, 2008 and June 30, 2009, changes in tax
    laws or tax rates, and our ability to utilize our deferred tax assets;
    our ability to effectively implement, manage and maintain our global
*   information systems and maintain the security of our confidential data and
    our employees' and customers' personal information;
    our reliance on third parties for certain outsourced business services,
*   including information technology operations and employee benefit plan
    administration;
    the potential for significant impairment charges relating to our
*   trademarks, goodwill or other intangible assets that could result from a
    number of factors, including downward pressure on our stock price; and
*   other unanticipated risks and uncertainties.
    

We caution that the factors described herein could cause actual results to
differ materially from those expressed in any forward-looking statements we
make and that investors should not place undue reliance on any such
forward-looking statements. Further, any forward-looking statement speaks only
as of the date on which such statement is made, and we undertake no obligation
to update any forward-looking statement to reflect events or circumstances
after the date on which such statement is made or to reflect the occurrence of
anticipated or unanticipated events or circumstances. New factors emerge from
time to time, and it is not possible for us to predict all of such factors.
Further, we cannot assess the impact of each such factor on our results of
operations or the extent to which any factor, or combination of factors, may
cause actual results to differ materially from those contained in any
forward-looking statements. This press release is qualified in its entirety by
the cautionary statements and risk factor disclosure contained in our
Securities and Exchange Commission filings, including our Annual Report on
Form 10-K for the year ended June 30, 2012.

Contact:

Elizabeth Arden, Inc.
Marcey Becker, Senior Vice President, Finance
or
Investor/Press Contact:
Integrated Corporate Relations
Allison Malkin/Michael Fox, 203-682-8200
 
Press spacebar to pause and continue. Press esc to stop.